Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

MITF::CREM-rearranged tumor: a novel group of cutaneous tumors with melanocytic differentiation

A. Kalmykova, E. Mosaieby, D. Kacerovská, V. Baranovska-Andrigo, P. Martínek, S. Smahová, M. Michal, M. Michal

. 2023 ; 483 (4) : 569-575. [pub] 20230808

Language English Country Germany

Document type Case Reports, Journal Article

E-resources Online Full text

NLK ProQuest Central from 2003-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2011-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2003-01-01 to 1 year ago

Cutaneous tumors with melanocytic differentiation represent a broad group of neoplasms of both melanocytic and non-melanocytic origin. Besides traditional members such as clear-cell sarcoma (CCS) and PEComa, the latter group has recently expanded to also include MITF::CREM fusion-associated tumors, but the available data are limited. Herein, we present a third case of this rare neoplasm which occurred in the temporal region in a 1-year-old girl. It was an infiltratively growing polypoid dermal-based lesion lacking an intraepidermal component. It consisted of cellular solid sheets or small nests of epithelioid to spindled cells with a predominantly eosinophilic and much less commonly clear cytoplasm. The nuclei had round to ovoid shape and exhibited moderate to high-grade atypia and prominent nucleoli. The mitotic activity was 11 mitoses per 10 high-power fields, and atypical mitotic figures were present. Immunohistochemically, the tumor was strongly positive with S100 protein, SOX10, and MITF, while HMB45, tyrosinase, and Melan A were negative. Extensive molecular analysis revealed only MITF::CREM gene fusion. There had no evidence of disease 9 months after the diagnosis. These tumors need to be distinguished from malignant tumors with melanocytic differentiation, primarily from melanoma. However, additional cases still need to be studied to precisely define their biological potential and establish their nosologic status.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001169
003      
CZ-PrNML
005      
20240213094415.0
007      
ta
008      
240109s2023 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00428-023-03621-7 $2 doi
035    __
$a (PubMed)37550584
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Kalmykova, Antonina $u Medical Laboratory CSD Health Care, Ltd., Kyiv, Ukraine $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic
245    10
$a MITF::CREM-rearranged tumor: a novel group of cutaneous tumors with melanocytic differentiation / $c A. Kalmykova, E. Mosaieby, D. Kacerovská, V. Baranovska-Andrigo, P. Martínek, S. Smahová, M. Michal, M. Michal
520    9_
$a Cutaneous tumors with melanocytic differentiation represent a broad group of neoplasms of both melanocytic and non-melanocytic origin. Besides traditional members such as clear-cell sarcoma (CCS) and PEComa, the latter group has recently expanded to also include MITF::CREM fusion-associated tumors, but the available data are limited. Herein, we present a third case of this rare neoplasm which occurred in the temporal region in a 1-year-old girl. It was an infiltratively growing polypoid dermal-based lesion lacking an intraepidermal component. It consisted of cellular solid sheets or small nests of epithelioid to spindled cells with a predominantly eosinophilic and much less commonly clear cytoplasm. The nuclei had round to ovoid shape and exhibited moderate to high-grade atypia and prominent nucleoli. The mitotic activity was 11 mitoses per 10 high-power fields, and atypical mitotic figures were present. Immunohistochemically, the tumor was strongly positive with S100 protein, SOX10, and MITF, while HMB45, tyrosinase, and Melan A were negative. Extensive molecular analysis revealed only MITF::CREM gene fusion. There had no evidence of disease 9 months after the diagnosis. These tumors need to be distinguished from malignant tumors with melanocytic differentiation, primarily from melanoma. However, additional cases still need to be studied to precisely define their biological potential and establish their nosologic status.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    12
$a nádory kůže $x patologie $7 D012878
650    12
$a melanom $x diagnóza $7 D008545
650    _2
$a melanocyty $x patologie $7 D008544
650    12
$a sarkom z jasných buněk $x genetika $7 D018227
650    _2
$a buněčná diferenciace $7 D002454
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a transkripční faktor spojený s mikroftalmií $x genetika $x metabolismus $7 D051739
650    _2
$a modulátor elementu responzivního pro cyklický AMP $x metabolismus $7 D051786
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mosaieby, Elaheh $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
700    1_
$a Kacerovská, Denisa $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
700    1_
$a Baranovska-Andrigo, Vira $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
700    1_
$a Martínek, Petr $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
700    1_
$a Smahová, Sabína $u Department of Pediatric Hematology and Oncology, National Institute of Children's Diseases and Medical Faculty, Comenius University, Bratislava, Slovakia
700    1_
$a Michal, Michal $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic $u Bioptical Laboratory, Ltd., Plzen, Czech Republic
700    1_
$a Michal, Michael $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic. michael.michal@biopticka.cz $u Bioptical Laboratory, Ltd., Plzen, Czech Republic. michael.michal@biopticka.cz $1 https://orcid.org/0000000344037027
773    0_
$w MED00004660 $t Virchows Archiv $x 1432-2307 $g Roč. 483, č. 4 (2023), s. 569-575
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37550584 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213094412 $b ABA008
999    __
$a ok $b bmc $g 2049647 $s 1210863
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 483 $c 4 $d 569-575 $e 20230808 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
LZP    __
$a Pubmed-20240109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...